To view this email as a web page, click here.
 
TOP STORIES
 
Top Barriers to Value-Based Pharma Pricing Models
Drug makers and payers have these challenges to implement outcomes-based contracts, but here are three steps that can be taken as a transition toward these payment arrangements.
Read more
ADVERTISEMENT
 
Pharma Pipeline Report: 7 Drugs Health Execs Should Watch
Unique trends are occurring in the pharmaceutical pipeline that would have been unheard of just five years ago.
Read more
ADVERTISEMENT
 
FDA Plans to Research Drug Advertising: 4 Things to Know
The goal is to help ensure that prescription drug marketing information for consumers and healthcare providers is truthful, balanced, and accurately communicated. Here’s what it plans to research.
Read more
 
DIGITAL EDITION
Check out our April issue featuring:
 • Five Diabetes Treatment Advances to Watch
 • Ramp Up Physician Engagement
 • Diabetes Pipeline Developments
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.